Two Sigma Securities, LLC Monopar Therapeutics Transaction History
Two Sigma Securities, LLC
- $8.19 Billion
- Q2 2024
A detailed history of Two Sigma Securities, LLC transactions in Monopar Therapeutics stock. As of the latest transaction made, Two Sigma Securities, LLC holds 47,058 shares of MNPR stock, worth $726,104. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,058Holding current value
$726,104% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding MNPR
# of Institutions
10Shares Held
379KCall Options Held
0Put Options Held
0-
Israel Englander Millennium Management LLC | New York, Ny194KShares$3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA60KShares$926,3550.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA45.2KShares$696,9260.0% of portfolio
-
Virtu Financial LLC New York, NY18.8KShares$290,7010.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY7.92KShares$122,2360.0% of portfolio
About Monopar Therapeutics
- Ticker MNPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,725,800
- Market Cap $196M
- Description
- Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe ...